Erik Milch > Proskauer Rose LLP > New York, United States > Lawyer Profile

Proskauer Rose LLP
11 TIMES SQUARE
NEW YORK, NEW YORK 10036-8299
NEW YORK
United States
Erik Milch photo

Work Department

Litigation

Position

Erik Milch is a partner in Proskauer’s Litigation Department and a member of the Intellectual Property, Patent Law and Trials group.

Erik brings more than 20 years of experience litigating in key jurisdictions across the U.S., as well as before the International Trade Commission and the U.S. Patent and Trademark Office. As a first-chair trial lawyer, Erik litigates complex matters involving medical devices, life sciences instrumentation, pharmaceuticals, electrical and computer technology, and consumer products. He regularly counsels clients in a range of industries in connection with patent procurement, development of patent portfolios, patent licensing, valuation of patent portfolios in business transactions and transactional diligence.

Erik has extensive experience in all aspects of patent litigation from pre-filing through appeal, including enforcement of patents against competitors and defense of patent infringement allegations. His technical background includes microfluidics, lab automation, optical imaging instruments, wound closure, surgical instrumentation, orthopedics, autoinjectors, tissue resection and sealing, pharmaceuticals, haptic feedback systems, computer software, consumer products, fluid mechanics applications, automotive engines and mechanical and electrical components, aerospace propulsion and control systems, weapons systems, and telecommunications.

Prior to pursuing a legal career, Erik earned a bachelor’s degree in mechanical engineering from Georgia Tech, where he developed a deep appreciation for cutting-edge technology and its potential to drive progress. His background in engineering equips him with a unique ability to comprehend intricate technical concepts. This enables him to effectively navigate the intricate world of patent litigation, combining his legal skills with technical know-how to provide comprehensive and strategic counsel to his clients.

In addition to his academic accomplishments, Erik served as an officer in the United States Navy. His military background instilled in him a strong sense of discipline, leadership, perseverance, and attention to detail; qualities that continue to guide him in his legal practice.

Lawyer Rankings

United States > Media, technology and telecoms > Advertising and marketing: litigation

Lanham Act disputes and advertising challenges before the NAD and NARB are key expertise of Proskauer Rose LLP. The New York-based practice also represents clients from a range of sectors in false advertising claims, marketing and unfair competition claims, and IP disputes. Leading the team is Baldassare Vinti, who is adept in IP litigation with a focus on advertising and patent law andexperience handling cases in federal and state courts, as well as before the Patent Trial and Appeal Board, the International Trade Commission, and international arbitration tribunals. Other key members of the team are Jeffrey Warshafsky – who specializes in consumer class actions, sports litigation, false advertising, and IP disputes – and Jennifer Yang – who concentrates on false advertising claims and IP disputes. They are both regularly involved in representing clients before the NAD and NARB. The practice has notably had four partners join the team in 2023, Erik Milch and Joseph Drayton from Cooley LLP; and Grant Esposito and David Fioccola from Morrison Foerster.

United States > Healthcare > Life sciences

Proskauer Rose LLP‘s life sciences practice is particularly adept at handling multi-faceted patent disputes concerning biologics, medical devices and pharmaceutical developments, and 2023 saw the team expand with the arrivals of Erik Milch in Washington DC and Joseph Drayton in New York from Cooley LLP in July and October respectively, while Morrison Foerster‘s Grant Esposito and David Fioccola also joined the New York office in October. The team is led by Boston’s ‘excellent patent lawyer’ Fangli Chen, whose litigious experience encompasses immunotherapy, gene therapy and editing and vaccines, and managing partner and transactions specialist Daryn Grossman in New York. Siegmund Gutman has left the firm.